Trial Condition(s):
N/A
Utilization and Continuation Rates of Skyla
Bayer Identifier:
18857
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Study Completed
Trial Purpose
Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available
Trial Summary
Enrollment Goal
99999
Trial Dates
Phase
N/A
Could I receive a placebo?
No
Products
Skyla (Levonorgestrel, BAY86-5028)
Accepts Healthy Volunteers
Yes
Where to Participate
Loading...
Locations
Status
| Locations | Status | |
|---|---|---|
Locations Investigative Site N/A, United States | Status Completed | Contact Us: E-mail: [email protected] Phone: Not Available |
Trial Design
A Retrospective Analysis to Estimate the 12-month Continuation Rates of Levonorgestrel Intrauterine System (LNG-IUS) 13.5 mg and Subdermal Etonogestrel (ENG) Implant in a Commercially-Insured Population in the U.S.
Trial Type:
Observational
Intervention Type:
N/A
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
N/A
Primary Outcome
- Twelve-month discontinuation rates of LNG-IUS 8 and ENG implant using a large US claims databaseTimeframe:
Additional Information
Copyright © Bayer
Powered by
